Our Approach

We are the corporate venture capital arm for Sanofi. We invest in top tier biotherapeutic and digital health entrepreneurs who focus on helping patients and disrupting the healthcare system. We can lead financings and drive longterm value from our first investments in Seeds to Series B's.

Who we are

We are investors in top tier biotherapeutic and digital health entrepreneurs who focus on helping patients and transforming the healthcare system.

What we do

We act similarly to institutional venture capitalists; we have the ability to lead, co-lead, or seed companies. We partner with management on their boards and make equity investments.

Our raison d'être

We provide a low-cost, self-sustaining vehicle enabling our parent company to engage with the early stage innovation ecosystem when companies are too risky or early to in-license or acquire.

How we work

Think of us like institutional venture capitalists with the added bonus that in addition to our investment, we aim to offer our portfolio companies select access to Sanofi’s established expertise and capabilities in science, preclinical and clinical development, regulatory, manufacturing, market access, and commercialization when helpful to our portfolio companies.

Our goal is to foster these relationships over time so when our portfolio company is ready to consider a license or acquisition, our colleagues on the BD and M&A teams are their first choice and last call.

We move quickly; we don’t believe in drawn-out processes, and we always aim to provide thoughtful feedback.

Our Investment Focus

We invest in top tier biotherapeutic and digital health entrepreneurs who focus on helping patients and radically transforming the healthcare ecosystem.

Our venture model serves as an "innovation front door" to Sanofi.  We seek to accelerate all strategic focus areas while reaching into novel and emerging areas of science and technology.

Here are some of the areas that we currently are thinking about:

  • Rare diseases
  • Immunology and inflammation
  • Oncology
  • Cell and gene therapy
  • Vaccines
  • Digital health and data science solutions

We can't do it alone - we would love to hear how you can partner with us to change the healthcare world!